|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/17 | (2006.01) |
| A61K 9/08 | (2006.01) |
| (11) | Number of the document | 1778723 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05789252.3 |
| Date of filing the European patent application | 2005-08-17 | |
| (97) | Date of publication of the European application | 2007-05-02 |
| (45) | Date of publication and mention of the grant of the patent | 2012-11-14 |
| (46) | Date of publication of the claims translation | 2013-03-25 |
| (86) | Number | PCT/US2005/029428 |
| Date | 2005-08-17 |
| (87) | Number | WO 2006/023665 |
| Date | 2006-03-02 |
| (30) | Number | Date | Country code |
| 602137 P | 2004-08-17 | US |
| (72) |
DIX, Daniel, US
BOWERS, Katherine, US
CHIMANLALL, Goolcharran, US
|
| (73) |
REGENERON PHARMACEUTICALS, INC.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | IL-1 antagonisto kompozicijos |
| IL-1 ANTAGONIST FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2021-07-20 | 17 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-08-17 |